To control hyperglycemia in type-2 diabetes, several therapeutic non-insulin hypoglycemic agents are currently employed.7 In this context, metformin hydrochloride (MET) is nowadays considered as a prominent treatment for type-2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.